Who is sponsoring NCT02865421?

NCT02865421 is sponsored by King Edward Medical University.

What drugs are being tested in NCT02865421?

Interventions in NCT02865421: stem cells, platelet rich plasma.

What condition does NCT02865421 study?

NCT02865421 studies Combination of SVF and PRP for Androgenetic Alopecia.

Is NCT02865421 still recruiting?

NCT02865421 is currently completed. Last updated 11 January 2018.

Last reviewed 2018-01-11 · How we verify

NCT02865421: AGA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

Completed Phase 2 Last updated 11 January 2018

What this trial tests

Phase 2 trial testing stem cells in Combination of SVF and PRP for Androgenetic Alopecia in 22 participants. Completed in 31 December 2017.

Timeline

10 June 2017

Primary endpoint
12 August 2017

31 December 2017

Quick facts

Lead sponsor	King Edward Medical University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	10 June 2017
Primary completion	12 August 2017
Estimated completion	31 December 2017
Sites	1 location across Pakistan

Drugs / interventions tested

stem cells — full drug profile →
platelet rich plasma — full drug profile →

Conditions studied

Combination of SVF and PRP for Androgenetic Alopecia — all drugs for Combination of SVF and PRP for Androgenetic Alopecia →

Sponsor

King Edward Medical University

Who can join

Adults 15 to 70, any sex, with Combination of SVF and PRP for Androgenetic Alopecia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, characterized by progressive patterned loss of hair from the scalp. The current study has been designed for restoration of hair in AGA by using a combination of stromal vascular fraction (derived from the adipose tissue) and human platelet rich plasma.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging.
Gaur M, Dobke M, Lunyak VV. · · 2017 · cited 105× · PMID 28117680 · DOI 10.3390/ijms18010208
Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
Shimizu Y, Ntege EH, Sunami H, Inoue Y. · · 2022 · cited 77× · PMID 36382136 · DOI 10.1016/j.reth.2022.10.005
Therapeutic Potential of Stem Cells in Follicle Regeneration.
Owczarczyk-Saczonek A, Krajewska-Włodarczyk M, Kruszewska A, Banasiak Ł, et al · · 2018 · cited 46× · PMID 30154860 · DOI 10.1155/2018/1049641
The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds).
Owczarczyk-Saczonek A, Wociór A, Placek W, Maksymowicz W, et al · · 2017 · cited 22× · PMID 28904532 · DOI 10.1155/2017/4740709
Advances in Stem Cell-Based Therapy for Hair Loss.
Egger A, Tomic-Canic M, Tosti A. · · 2020 · cited 20× · PMID 32968692
Stromal Vascular Fraction and its Role in the Management of Alopecia: A Review.
Stefanis AJ, Groh T, Arenbergerova M, Arenberger P, et al · · 2019 · cited 12× · PMID 32038756

Verify or expand the search:

Other trials of stem cells

Trials testing the same drug.

NCT04653077 — MSCs Therapy for Cerebral Palsy · NA · unknown
NCT04972890 — The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dy · Phase 2, PHASE3 · unknown
NCT04393415 — Using PRP and Cord Blood in Treatment of Covid -19 · NA · unknown
NCT01625351 — A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumor · Phase 1 · completed

Other King Edward Medical University trials

Trials by the same sponsor.

NCT07480447 — Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting · NA · not yet recruiting
NCT07428265 — Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision · NA · recruiting
NCT07368439 — Effect of Feedback-Based Balance Training on Balance and Gait in Cancer Patients With Chemotherapy-Induced Peripheral Ne · NA · not yet recruiting
NCT07210424 — Comparative Study on the Post-operative Pain and Other Outcomes of Mesh Fixation With Prolene vs Vicryl vs Skin Staples · not yet recruiting
NCT07267260 — Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controll · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02865421 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Edward Medical University
Last refreshed: 11 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02865421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing